Literature DB >> 3148813

Pathogenesis of scrapie is faster when infection is intraspinal instead of intracerebral.

R H Kimberlin1, S Cole, C A Walker.   

Abstract

Previous studies of mice infected peripherally with 139A scrapie showed that scrapie agent initially replicates outside the CNS and that invasion of the CNS occurs several weeks later by neural spread of infection along visceral autonomic fibres to the mid-thoracic cord, and thence to brain. Direct intracerebral infection of brain bypasses the need for extraneural replication and gives shorter incubation periods than peripheral routes. However, it was also found that the duration of the scrapie replication phase in brain, before clinical disease develops, is actually shorter with peripheral routes than with the intracerebral route. We have now investigated this surprising observation using the intraspinal route to reproduce just the neural phase of scrapie pathogenesis seen after peripheral infection. In studies of three strains of scrapie (263K, 139A and ME7) in either hamsters or mice, we have fulfilled the prediction that incubation periods should be shorter after intraspinal infection than after intracerebral infection. Detailed studies of 139A scrapie showed that the shorter incubation period by the intraspinal route could be accounted for by the shorter duration of the scrapie replication phase in brain before clinical disease developed. As a consequence, the severity of the vacuolar lesions in brain at the clinical stage of all three scrapie models was less after intraspinal infection than after intracerebral infection but the severities of vacuolation after intraspinal and intraperitoneal infection were remarkably similar. We speculate that (a) the site of injection (or of invasion) of the central nervous system determines which neural pathways become accessible for the spread of scrapie infection, and that (b) the duration of the neural phase of scrapie pathogenesis is related to the complexity of the pathways between the site of invasion and the clinical target areas in which, it is suggested, scrapie must replicate for disease to develop.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3148813     DOI: 10.1016/0882-4010(87)90047-7

Source DB:  PubMed          Journal:  Microb Pathog        ISSN: 0882-4010            Impact factor:   3.738


  19 in total

1.  Transport of prion protein across the blood-brain barrier.

Authors:  W A Banks; Sandra M Robinson; R Diaz-Espinoza; A Urayama; C Soto
Journal:  Exp Neurol       Date:  2009-05-05       Impact factor: 5.330

2.  Crucial role for prion protein membrane anchoring in the neuroinvasion and neural spread of prion infection.

Authors:  Mikael Klingeborn; Brent Race; Kimberly D Meade-White; Rebecca Rosenke; James F Striebel; Bruce Chesebro
Journal:  J Virol       Date:  2010-12-01       Impact factor: 5.103

Review 3.  Prion Strain Diversity.

Authors:  Jason C Bartz
Journal:  Cold Spring Harb Perspect Med       Date:  2016-12-01       Impact factor: 6.915

4.  Search for a prion-specific nucleic acid.

Authors:  Jiri G Safar; Klaus Kellings; Ana Serban; Darlene Groth; James E Cleaver; Stanley B Prusiner; Detlev Riesner
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

5.  Alimentary prion infections: Touchdown in the intestine.

Authors:  Bianca Da Costa Dias; Katarina Jovanovic; Stefan F T Weiss
Journal:  Prion       Date:  2011-01-01       Impact factor: 3.931

6.  Spread of Creutzfeldt-Jakob disease virus along visual pathways after intraocular inoculation.

Authors:  P P Liberski; R Yanagihara; C J Gibbs; D C Gajdusek
Journal:  Arch Virol       Date:  1990       Impact factor: 2.574

7.  Role of interleukin-1 in prion disease-associated astrocyte activation.

Authors:  Julia Schultz; Anja Schwarz; Sabine Neidhold; Michael Burwinkel; Constanze Riemer; Dietrich Simon; Manfred Kopf; Markus Otto; Michael Baier
Journal:  Am J Pathol       Date:  2004-08       Impact factor: 4.307

Review 8.  Experimental drug treatment of scrapie: a pathogenetic basis for rationale therapeutics.

Authors:  M Pocchiari; M Salvatore; A Ladogana; L Ingrosso; Y G Xi; M Cibati; C Masullo
Journal:  Eur J Epidemiol       Date:  1991-09       Impact factor: 8.082

9.  Intramuscular injection of α-synuclein induces CNS α-synuclein pathology and a rapid-onset motor phenotype in transgenic mice.

Authors:  Amanda N Sacino; Mieu Brooks; Michael A Thomas; Alex B McKinney; Sooyeon Lee; Robert W Regenhardt; Nicholas H McGarvey; Jacob I Ayers; Lucia Notterpek; David R Borchelt; Todd E Golde; Benoit I Giasson
Journal:  Proc Natl Acad Sci U S A       Date:  2014-07-07       Impact factor: 11.205

10.  Prion strain targeting independent of strain-specific neuronal tropism.

Authors:  Jacob I Ayers; Anthony E Kincaid; Jason C Bartz
Journal:  J Virol       Date:  2008-10-29       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.